ZBH

$87.87-1.97 (-2.19%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$87.87
Potential Downside
22%
Whystock Fair Value$68.50
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, inclu...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$17.41B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
24.75
Beta
Defensive asset. Lower volatility than the S&P 500.
0.59
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
6.49%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.10

Recent News

Motley Fool
Mar 20, 2026

Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6?

Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
StockStory
Mar 19, 2026

Surgical Equipment & Consumables - Diversified Stocks Q4 In Review: Zimmer Biomet (NYSE:ZBH) Vs Peers

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Zimmer Biomet (NYSE:ZBH).

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Barchart
Mar 16, 2026

How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks?

Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Simply Wall St.
Mar 15, 2026

Zimmer Biomet (ZBH) Valuation Check After Earnings Beat And Updated Growth Outlook

Zimmer Biomet Holdings (ZBH) just reported fourth quarter 2025 results that topped adjusted earnings expectations, alongside 10.9% year over year net sales growth and new guidance for 2026 revenue and earnings. See our latest analysis for Zimmer Biomet Holdings. At a share price of $93.20, Zimmer Biomet’s 1-day share price return of 0.66% and 90-day share price return of 1.76% sit against a 1-year total shareholder return decline of 14.41%, which points to some recent momentum after a weaker...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

ISRG's da Vinci Gains FDA Nod for Cardiac Surgery: TAM Growth Ahead?

ISRG targets cardiac surgery as a long-term da Vinci 5 growth driver after FDA clearance, eyeing nearly 160,000 potential procedures in cleared markets vs approximately 17,000 today.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.